We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
(-8.1%)
Cap. Flow
-$941M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$293M |
| 2 |
Micron Technology
MU
|
+$214M |
| 3 |
Texas Instruments
TXN
|
+$174M |
| 4 |
Las Vegas Sands
LVS
|
+$136M |
| 5 |
SF
Stifel
SF
|
+$108M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$284M |
| 2 |
O'Reilly Automotive
ORLY
|
+$241M |
| 3 |
Arista Networks
ANET
|
+$239M |
| 4 |
Comfort Systems
FIX
|
+$218M |
| 5 |
Meta Platforms (Facebook)
META
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.74% |
| 2 | Financials | 13.54% |
| 3 | Consumer Discretionary | 13.12% |
| 4 | Industrials | 11.88% |
| 5 | Healthcare | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Expensify
EXFY
$168M
| $41.6K | ﹤0.01% |
47,816
+32,183
| +206% | +$38.2K |
|
952
Acumen Pharmaceuticals
ABOS
$157M
| $30.7K | ﹤0.01% |
+13,011
| New | +$33.2K |
|
953
Destination XL Group
DXLG
$34.5M
| $8.49K | ﹤0.01% |
+16,649
| New | +$10.7K |
|
954
ABM Industries
ABM
$2.77B
| – | – |
-17,356
| Closed | -$734K |
|
955
Altimmune
ALT
$552M
| – | – |
-124,821
| Closed | -$451K |
|
956
Ametek
AME
$55.3B
| – | – |
-1,437
| Closed | -$295K |
|
957
AMN Healthcare
AMN
$1.28B
| – | – |
-61,195
| Closed | -$964K |
|
958
American Well
AMWL
$180M
| – | – |
-119,849
| Closed | -$588K |
|
959
AptarGroup
ATR
$8.23B
| – | – |
-4,516
| Closed | -$551K |
|
960
Atossa Therapeutics
ATOS
$24M
| – | – |
-69,886
| Closed | -$618K |
|
961
American Vanguard Corp
AVD
$72.4M
| – | – |
-173,756
| Closed | -$664K |
|
|
DCH
962
Dauch Corp
DCH
$1.33B
| – | – |
-563,139
| Closed | -$3.61M |
|
963
Booz Allen Hamilton
BAH
$7.9B
| – | – |
-38,015
| Closed | -$3.21M |
|
964
BARK
BARK
$77.3M
| – | – |
-4,206
| Closed | -$50.7K |
|
|
BFS
965
Saul Centers
BFS
$865M
| – | – |
-6,641
| Closed | -$209K |
|
966
Biogen
BIIB
$29.6B
| – | – |
-9,873
| Closed | -$1.74M |
|
967
BILL Holdings
BILL
$4.11B
| – | – |
-31,815
| Closed | -$1.74M |
|
968
Broadstone Net Lease
BNL
$4.29B
| – | – |
-111,701
| Closed | -$1.94M |
|
969
Brady Corp
BRC
$4.41B
| – | – |
-6,901
| Closed | -$541K |
|
970
Braze
BRZE
$2.39B
| – | – |
-304,243
| Closed | -$10.4M |
|
971
Cardinal Health
CAH
$52.9B
| – | – |
-1,514
| Closed | -$311K |
|
972
Cal-Maine
CALM
$4.18B
| – | – |
-34,193
| Closed | -$2.72M |
|
973
CAVA Group
CAVA
$7.36B
| – | – |
-33,025
| Closed | -$1.94M |
|
974
Cullinan Oncology
CGEM
$1.06B
| – | – |
-73,755
| Closed | -$763K |
|
975
Ciena
CIEN
$57.7B
| – | – |
-88,927
| Closed | -$20.8M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2026 Portfolio in Review
As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.
- Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
- Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
- Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
- Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
- Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.